We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
Read MoreHide Full Article
In the latest trading session, Teladoc (TDOC - Free Report) closed at $140.53, marking a +0.04% move from the previous day. The stock lagged the S&P 500's daily gain of 0.3%.
Heading into today, shares of the telehealth services provider had gained 1.31% over the past month, outpacing the Medical sector's loss of 1.9% and lagging the S&P 500's gain of 4.28% in that time.
TDOC will be looking to display strength as it nears its next earnings release, which is expected to be October 27, 2021. In that report, analysts expect TDOC to post earnings of -$0.63 per share. This would mark a year-over-year decline of 384.62%. Meanwhile, our latest consensus estimate is calling for revenue of $516.66 million, up 78.89% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of -$3.53 per share and revenue of $2.01 billion, which would represent changes of -212.39% and +83.65%, respectively, from the prior year.
Any recent changes to analyst estimates for TDOC should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. TDOC is currently a Zacks Rank #3 (Hold).
The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 193, which puts it in the bottom 25% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Teladoc (TDOC) Gains But Lags Market: What You Should Know
In the latest trading session, Teladoc (TDOC - Free Report) closed at $140.53, marking a +0.04% move from the previous day. The stock lagged the S&P 500's daily gain of 0.3%.
Heading into today, shares of the telehealth services provider had gained 1.31% over the past month, outpacing the Medical sector's loss of 1.9% and lagging the S&P 500's gain of 4.28% in that time.
TDOC will be looking to display strength as it nears its next earnings release, which is expected to be October 27, 2021. In that report, analysts expect TDOC to post earnings of -$0.63 per share. This would mark a year-over-year decline of 384.62%. Meanwhile, our latest consensus estimate is calling for revenue of $516.66 million, up 78.89% from the prior-year quarter.
For the full year, our Zacks Consensus Estimates are projecting earnings of -$3.53 per share and revenue of $2.01 billion, which would represent changes of -212.39% and +83.65%, respectively, from the prior year.
Any recent changes to analyst estimates for TDOC should also be noted by investors. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.
Our research shows that these estimate changes are directly correlated with near-term stock prices. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.
Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. TDOC is currently a Zacks Rank #3 (Hold).
The Medical Services industry is part of the Medical sector. This industry currently has a Zacks Industry Rank of 193, which puts it in the bottom 25% of all 250+ industries.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions.